Table 1 Demographic data of group A (≥2, <12 months; n = 155)
From: The efficacy and safety of mivacurium in pediatric patients
Subgroups | n | Percentage in group A (%) | Sex (M/F) | Body weight (kg) | Induction dose (mg/kg) | Injecting time (s) |
|---|---|---|---|---|---|---|
Group 1 | 39 | 25 | 27/12 | 8.5 ± 2.4 | 0.15 | 20 |
Group 2 | 37 | 24 | 23/14 | 8.6 ± 2.2 | 0.15 | 40 |
Group 3 | 39 | 25 | 27/12 | 9.1 ± 2.4 | 0.20 | 20 |
Group 4 | 40 | 26 | 26/14 | 8.8 ± 2.0 | 0.20 | 40 |